Aclaris Therapeutics Statistics
Total Valuation
ACRS has a market cap or net worth of $152.68 million. The enterprise value is -$35.36 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ACRS has 108.28 million shares outstanding. The number of shares has increased by 27.19% in one year.
Current Share Class | 108.28M |
Shares Outstanding | 108.28M |
Shares Change (YoY) | +27.19% |
Shares Change (QoQ) | +28.42% |
Owned by Insiders (%) | 2.67% |
Owned by Institutions (%) | 53.06% |
Float | 67.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.15 |
Forward PS | 29.06 |
PB Ratio | 1.06 |
P/TBV Ratio | 1.06 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.02.
Current Ratio | 5.06 |
Quick Ratio | 4.91 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.03% and return on invested capital (ROIC) is -23.19%.
Return on Equity (ROE) | -91.03% |
Return on Assets (ROA) | -18.20% |
Return on Invested Capital (ROIC) | -23.19% |
Return on Capital Employed (ROCE) | -30.68% |
Revenue Per Employee | $277,766 |
Profits Per Employee | -$2.03M |
Employee Count | 64 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.03% in the last 52 weeks. The beta is 0.43, so ACRS's price volatility has been lower than the market average.
Beta (5Y) | 0.43 |
52-Week Price Change | +27.03% |
50-Day Moving Average | 1.34 |
200-Day Moving Average | 1.90 |
Relative Strength Index (RSI) | 58.19 |
Average Volume (20 Days) | 665,674 |
Short Selling Information
The latest short interest is 4.57 million, so 4.22% of the outstanding shares have been sold short.
Short Interest | 4.57M |
Short Previous Month | 4.45M |
Short % of Shares Out | 4.22% |
Short % of Float | 6.81% |
Short Ratio (days to cover) | 4.99 |
Income Statement
In the last 12 months, ACRS had revenue of $17.78 million and -$130.21 million in losses. Loss per share was -$1.45.
Revenue | 17.78M |
Gross Profit | -32.68M |
Operating Income | -54.18M |
Pretax Income | -59.05M |
Net Income | -130.21M |
EBITDA | -53.99M |
EBIT | -54.18M |
Loss Per Share | -$1.45 |
Full Income Statement Balance Sheet
The company has $105.31 million in cash and $2.48 million in debt, giving a net cash position of $188.04 million or $1.74 per share.
Cash & Cash Equivalents | 105.31M |
Total Debt | 2.48M |
Net Cash | 188.04M |
Net Cash Per Share | $1.74 |
Equity (Book Value) | 144.07M |
Book Value Per Share | 1.33 |
Working Capital | 87.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$12.32 million and capital expenditures -$29,000, giving a free cash flow of -$12.35 million.
Operating Cash Flow | -12.32M |
Capital Expenditures | -29,000 |
Free Cash Flow | -12.35M |
FCF Per Share | -$0.11 |
Full Cash Flow Statement Margins
Gross Margin | -183.84% |
Operating Margin | -304.78% |
Pretax Margin | -732.46% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.19% |
Shareholder Yield | -27.19% |
Earnings Yield | -85.28% |
FCF Yield | -8.09% |
Analyst Forecast
The average price target for ACRS is $9.71, which is 588.65% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.71 |
Price Target Difference | 588.65% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 35.94% |
EPS Growth Forecast (5Y) | -10.18% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -5.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.02 |
Piotroski F-Score | 2 |